Sangamo Therapeutics
SGMO
$3.58
Share price
3.77%
Change (1 day)
-35.14%
Change (1 year)
Categories
Earnings for Sangamo Therapeutics (SGMO)
Earnings in 2022 (TTM): -$0.19 B
According to Sangamo Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.19 B. In 2021 the company made an earning of -$0.19 B a decrease over its 2020 earnings that were of -$0.13 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Sangamo Therapeutics from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.19 B | 1.34% |
| 2021 | -$0.19 B | 41.52% |
| 2020 | -$0.13 B | 23.17% |
| 2019 | -$0.11 B | 36.33% |
| 2018 | -$77.15 M | 36.89% |
| 2017 | -$56.37 M | -22.32% |
| 2016 | -$72.56 M | 54.86% |
| 2015 | -$46.86 M | 76.48% |
| 2014 | -$26.56 M | -0.36% |
| 2013 | -$26.65 M | |
| 2011 | -$35.83 M | 43.66% |
| 2010 | -$24.94 M | 28.52% |
| 2009 | -$19.41 M | -23.55% |
| 2008 | -$25.38 M | 2.45% |
| 2007 | -$24.78 M | 19.5% |
| 2006 | -$20.73 M | 50.78% |
| 2005 | -$13.75 M | 75% |
| 2004 | -$7.86 M | -33.25% |
| 2003 | -$11.77 M | -62.27% |
| 2002 | -$31.2 M | 102.82% |
| 2001 | -$15.38 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.51 B | -12,220.80% | 🇺🇸 USA |
 Amgen AMGN | $7.72 B | -4,260.12% | 🇺🇸 USA |
 Biogen BIIB | $3.39 B | -1,926.28% | 🇺🇸 USA |
 Dow DOW | $7.34 B | -4,052.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $4.54 B | -2,544.72% | 🇺🇸 USA |
 Merck MRK | $17.77 B | -9,667.89% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$1.02 B | 447.61% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.10 B | -154.13% | 🇺🇸 USA |